Navigation Links
Keryx Biopharmaceuticals Receives Orphan-Drug Designation for KRX-0401 (Perifosine) for the Treatment of Multiple Myeloma
Date:9/16/2009

NEW YORK, Sept. 16 /PRNewswire/ -- Keryx Biopharmaceuticals, Inc. today announced that KRX-0401 (perifosine) has received Orphan-Drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma. In August, the Company announced that it had reached an agreement with the FDA regarding a Special Protocol Assessment (SPA) on the design of a Phase 3 trial in relapsed/refractory multiple myeloma and that the study is expected to start by year-end.

Ron Bentsur, Chief Executive Officer of Keryx, commented, "The Orphan-Drug designation for perifosine in multiple myeloma is a very important milestone for Keryx, as the market exclusivity protection provided by this designation significantly enhances the commercial opportunity of perifosine in this indication." Mr. Bentsur continued, "Following our exciting announcement last month that we had reached an agreement with the FDA on an SPA for a Phase 3 trial for perifosine in relapsed/refractory multiple myeloma, it is encouraging to further add to the value of the perifosine program with this Orphan-Drug designation. We look forward to commencing the Phase 3 study by year-end."

KRX-0401 (perifosine) is in-licensed by Keryx from Aeterna Zentaris, Inc. in the United States, Canada and Mexico.

About Orphan-Drug Designation

Orphan-drug designation is granted by the FDA Office of Orphan Drug Products to novel drugs or biologics that treat a rare disease or condition affecting fewer than 200,000 patients in the U.S. The designation provides the drug developer with a seven-year period of U.S. marketing exclusivity if the drug is the first of its type approved for the specified indication or if it demonstrates superior safety, efficacy, or a major contribution to patient care versus another drug of its type previously granted the designation for the same indication, as well as with tax credi
'/>"/>

SOURCE Keryx Biopharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
2. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia
3. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results
4. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2008 Financial Results on Tuesday, November 11, at 8:30 A.M. EST
5. Keryx Biopharmaceuticals KRX-0401 (Perifosine) Data Selected for Oral Presentation at the 50th Annual Meeting of the American Society of Hematology
6. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2008 Financial Results
7. Keryx Biopharmaceuticals Receives Nasdaq Notification
8. Keryx Biopharmaceuticals, Inc. Requests an Appeal Hearing After Receiving Notice of Delisting From Nasdaq
9. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2009 Financial Results
10. Keryx Biopharmaceuticals, Inc. Receives Extension for Nasdaq Listing Compliance
11. Keryx Biopharmaceuticals Inc. Regains Compliance With NASDAQ Listing Requirements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... Vegas, NV (PRWEB) , ... July 31, 2015 , ... ... bakery is now offering wedding cakes with custom designs, making life just ... to deliver beautifully designed wedding cakes for each customer who orders one. , The ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... and potential patients alike on various plastic surgery procedures including, but not limited ... such popular dermatology procedures like Botox and fillers. , Staying up to ...
(Date:7/31/2015)... Alexandria, VA (PRWEB) , ... July 31, 2015 ... ... Mesothelioma is a one-day event geared to patients and family members, medical professionals, ... local and regional mesothelioma experts. The conference is a collaborative effort between the ...
(Date:7/31/2015)... ... 2015 , ... Creating one of the most modern fertility centers in the ... that goes beyond the boundaries of fertility medicine. , As the leading gynecology ... dependable patient support, affordable treatments, unending hope, and high fertility success rates — all ...
(Date:7/31/2015)... ... July 31, 2015 , ... Girl Scouts of Historic Georgia and Peach ... the Girl Scout "Be a Friend First" program. Representatives from Peach State Health Plan ... “Peach State Health Plan and our parent company, Centene Corporation, are dedicated to raising ...
Breaking Medicine News(10 mins):Health News:Pastry Palace of Las Vegas Announces It Is Now Offering Custom Wedding Cakes in Las Vegas 2Health News:Cosmetic Town: Now Providing Interactive And Vital Medical Knowledge 2Health News:New York Area Mesothelioma Specialists to Present at Conference 2Health News:New York Area Mesothelioma Specialists to Present at Conference 3Health News:New Hope IVF Now Offers Most Affordable Assisted Reproductive Treatment in the UAE 2Health News:New Hope IVF Now Offers Most Affordable Assisted Reproductive Treatment in the UAE 3Health News:Peach State Health Plan Presents $10,000 Check for “Be a Friend First” Anti-Bullying Program to Local Girl Scouts 2
... Characterization of Dry-Patch ... Vaccine -, ... announced it will receive a,cost-reimbursement grant for up to $943,856 from the ... a,patch-based version of the anthrax vaccine., Under the 1-year grant, Iomai ...
... 2008 The Johns Hopkins University,School of Medicine ... of Patras, the third largest university in Greece, ... exchanges., The two schools will officially begin ... from the 43-year-old Greek public,institution visit Johns Hopkins ...
... with Mike Huckabee Share Behavior Change Successes ... and Discuss Healthcare Strategies and Trends, ... global leader in scalable behavior change interventions with outcomes,kicked ... was,attended by 250 industry experts and leading employers and ...
... service kicks off with genetic health showcase and demonstration ... ... April 8, 2008 Navigenics, a,privately held personalized health services company, ... health,assessment with the latest discoveries in science and medicine as well ...
... Launches Nationwide Bus and Concert Tour During STI Awareness ... ... the Trojan Evolve tour will travel across the U.S. raising,awareness regarding the poor ... fact is, this is not a sexually,healthy nation, and the Evolve tour is ...
... 8, 2008) Patient safety incidents cost the ... 238,337 potentially preventable deaths during 2004 through 2006, ... American Hospitals Study. HealthGrades, analysis of 41 million ... top-performing hospitals had, on average, a 43 percent ...
Cached Medicine News:Health News:Iomai Wins Department of Defense Grant to Develop a Stable, Patch-Based Anthrax Vaccine 2Health News:Iomai Wins Department of Defense Grant to Develop a Stable, Patch-Based Anthrax Vaccine 3Health News:Iomai Wins Department of Defense Grant to Develop a Stable, Patch-Based Anthrax Vaccine 4Health News:Johns Hopkins Medical School Sets Research and Teaching Collaboration with University of Patras in Greece 2Health News:HealthMedia Kicks Off ENGAGE Conference 2Health News:HealthMedia Kicks Off ENGAGE Conference 3Health News:Navigenics(TM) Launches Health Compass Service, a Personal Genetic Assessment for Optimal Health 2Health News:Navigenics(TM) Launches Health Compass Service, a Personal Genetic Assessment for Optimal Health 3Health News:Navigenics(TM) Launches Health Compass Service, a Personal Genetic Assessment for Optimal Health 4Health News:Navigenics(TM) Launches Health Compass Service, a Personal Genetic Assessment for Optimal Health 5Health News:Video: Rubber Hits the Road as Trojan(R) Campaigns for Sexual Health in America to Evolve 2Health News:Video: Rubber Hits the Road as Trojan(R) Campaigns for Sexual Health in America to Evolve 3Health News:Medical errors cost US $8.8B, result in 238,337 potentially preventable deaths: HealthGrades study 2Health News:Medical errors cost US $8.8B, result in 238,337 potentially preventable deaths: HealthGrades study 3Health News:Medical errors cost US $8.8B, result in 238,337 potentially preventable deaths: HealthGrades study 4
(Date:7/30/2015)... , July 30, 2015  Cleveland Clinic President ... 2015 keynote address last month that industry is compelled ... order to gain the efficiencies—and develop the transformational innovations ... Dr. Barsoum,s comments were preceded by Doug Kohrs ... and OMTEC moderator, who stressed that industry must add ...
(Date:7/30/2015)... N.J. , July 30, 2015  Growth of ... switches as they bring former prescription users to the ... Kline forecasts robust Rx-to-OTC switch activity over ... categories emerging along with many new brands entering the ... occur over the next five years (even those with ...
(Date:7/30/2015)... 2015 P&S Market ... market overview, trends, DRO analysis, market segmentation, ... developments, competitive scenario and top competitor profiles ... Market Development and Demand Forecast to 2020  ... Explore more about global biosensors ...
Breaking Medicine Technology:Orthopaedic Surgery Reimbursement Shifts to Episode of Care 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 3Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 2Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 3Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 4Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 5
... and MIAMI, Dec. 29, 2010 ... ("Matrixx" or the "Company") and H.I.G. Capital, LLC ("H.I.G."), ... the Federal Trade Commission has granted early termination of ... of 1976, as amended (the "HSR Act"), relating to ...
... HSKA ) ("Heska" or the "Company") today announced ... December 29, 2010, the stockholders of Heska voted to approve ... the Company,s issued and outstanding shares of common stock, together ... of the Company,s authorized stock and increase in the par ...
Cached Medicine Technology:Matrixx Initiatives, Inc. and H.I.G. Capital Announce Early Termination of HSR Waiting Period 2Matrixx Initiatives, Inc. and H.I.G. Capital Announce Early Termination of HSR Waiting Period 3Matrixx Initiatives, Inc. and H.I.G. Capital Announce Early Termination of HSR Waiting Period 4Heska Corporation Announces Stockholder Approval of Reverse Split 2Heska Corporation Announces Stockholder Approval of Reverse Split 3Heska Corporation Announces Stockholder Approval of Reverse Split 4
Urethral Red Rubber Catheters (Latex)...
Coude Foley Catheters (Latex) 2-Way Red...
Silicone Elastomer-Coated Latex Foley Catheters 3-Way...
Midstream Catch Kits...
Medicine Products: